Regulatory approval to initiate first-in-human study with a miniature, ultra long-acting GLP-1 (exenatide) implant in obese ...

The majority of our real estate footprint for the next several years, we sold our hemophilia a program and related technology to Novo Nordisk for $40 million. We received FDA approval in the third ...

Nov. 12—WATERTOWN — The Fort Drum Regional Health Planning Organization and North Country Health Compass Partners have ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Disruptive analytics’ Substack by Magnus Ofstad. In this article ...